Clinical Trials on Human Immunodeficiency Virus (HIV)

Total 11574 results

ViiV Healthcare
GlaxoSmithKline

Terminated

A Study to Evaluate the Pharmacokinetics of an Oral Contraceptive When Co-administered With GSK2248761 in Healthy Adult Female Subjects.

HIV Infections | Infection, Human Immunodeficiency Virus

United States
ViiV Healthcare

Completed

Study to Evaluate the Pharmacokinetics of an Oral Contraceptive Containing Levonorgestrel and Ethinyl Estradiol When Co-administered With GSK1265744 in Healthy Adult Female Subjects

Infections, Human Immunodeficiency Virus and Hepatitis

United Kingdom
G & W Laboratories Inc.
Alquest; SMART Biotech Ltd

Completed

Comparison of Plasma & SMARTplasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Antibody Testing

Hepatitis C | Human Immunodeficiency Virus Infection

United States
University of California, San Francisco
National Institute on Minority Health and Health Disparities (NIMHD); Florida...

Recruiting

The OPENS Trial: Offering Women PrEP (Aim 2)

Sexually Transmitted Diseases | Human Immunodeficiency Virus | Human Immunodeficiency Virus Transmission

United States
National Cancer Institute (NCI)

Completed

Phase I Protocol for the Evaluation of the Safety and Immunogenicity of Vaccination With Synthetic HIV Envelope Peptides in Patients With Early Human Immunodeficiency Virus Infection

Acquired Immunodeficiency Syndrome | HIV Infection

United States
Tufts University

Completed

Human Immunodeficiency Virus (HIV), Arterial Dysfunction, Lipids, Lovaza (HALO) Trial (HALO)

HIV Infection | Cardiovascular Disease

United States
Montefiore Medical Center
National Cancer Institute (NCI); University of Rwanda; Rwanda Military Hospital

Recruiting

HPV Vaccine Effectiveness Study in Rwandan Women Living With HIV

Cervical Cancer | Human Immunodeficiency Virus | HPV-Related Carcinoma | Human Papilloma Virus

Rwanda
Vir Biotechnology, Inc.
Bill and Melinda Gates Foundation

Completed

VIR-1111: A Prototype Human CMV-based Vaccine for Human Immunodeficiency Virus (HIV) in Healthy Volunteers

HIV I Infection

United States
ViiV Healthcare

Active, not recruiting

A Study to Evaluate Efficacy, Safety and Tolerability in Antiretroviral Therapy (ART)-Experienced Participants of at Least 50 Years of Age Living With Human Immunodeficiency Virus (HIV) With Virologic Suppression Who Switch to DTG/3TC FDC From BIC/FTC/TAF (EYEWITNESS)

HIV Infections | HIV

Netherlands, Germany, Mexico, Spain, United States, Belgium, Portugal, Canada, United Kingdom, Italy, Austria, France
Yale University
National Institute on Drug Abuse (NIDA); Baystate Medical Center

Completed

Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations (NewHope)

HIV | Opioid Dependence | AIDS | Drug Dependence

United States
University of California, San Francisco
National Institute of Mental Health (NIMH); University of Pennsylvania; Duke... and other collaborators

Completed

Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in Men

HIV Infections | Acquired Immunodeficiency Syndrome | RNA Virus Infections | Virus Diseases | Sexually Transmitted Diseases, Viral | Retroviridae Infections | Human Immunodeficiency Virus | Virus-HIV

Kenya
McGill University
Posit Science Corporation

Completed

Cognitive Training for the Remediation of Functional Brain Health in HIV

Cognitive Impairment | HIV - Human Immunodeficiency Virus

Canada
Biocodex

Completed

Treatment of Patients With Human Immunodeficiency Virus (HIV)-Related Chronic Diarrhea With Saccharomyces Boulardii or Placebo: A Double Blind Trial

HIV Infections | Diarrhea

United States
University Hospital, Bordeaux

Completed

Sexual Hepatitis C in HIV Positive Men Who Have Sex With Men (MSM) in Bordeaux (HEPCSEX)

Human Immunodeficiency Virus (HIV) | Hepatitis c

France
Brown University
National Institute on Drug Abuse (NIDA); University of California, San Diego; Beth Israel Deaconess Medical Center and other collaborators

Recruiting

Pre-exposure Prophylaxis (PrEP) for Health (PrEP)

Substance Dependence | HIV (Human Immunodeficiency Virus)

United States
ViiV Healthcare
GlaxoSmithKline; Janssen Pharmaceuticals

Active, not recruiting

Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults

HIV Infections | Infection, Human Immunodeficiency Virus

Germany, Spain, France, United States, Canada, Australia, Korea, Republic of, Italy, South Africa, Russian Federation, Argentina, Mexico, Sweden
CytoDyn, Inc.
Amarex Clinical Research

Completed

Treatment Substitution With PRO 140 Monotherapy in Adult Subjects With HIV-1 Infection

HIV | Human Immunodeficiency Virus

United States
Mayo Clinic
Takeda

Completed

The Effect of Ixazomib on the Latent HIV Reservoir

Human Immunodeficiency Virus (HIV)

United States
Karolinska Institutet
Hanoi Medical University

Unknown

Assessment of Group Peer Support to Children With HIV in Vietnam

Human Immunodeficiency Virus (HIV)

Vietnam
University of California, San Francisco
National Institute of Allergy and Infectious Diseases (NIAID); Monash University and other collaborators

Completed

Short-term Disulfiram Administration to Reverse Latent HIV Infection: a Dose Escalation Study

HIV | Human Immunodeficiency Virus

United States, Australia
Hunter College of City University of New York
National Institute on Alcohol Abuse and Alcoholism (NIAAA); Gilead Sciences

Completed

Intervention to Enhance PrEP Uptake and Adherence in a Community-Based Setting (SPARK)

Human Immunodeficiency Virus (HIV)

United States
ViiV Healthcare
Pfizer

No longer available

A Treatment Access Program To Provide Maraviroc To Eligible Adult Patients Completing A4001050 Study Until Commercial Availability Of Maraviroc (Celsentri) In India

Human Immunodeficiency Virus (HIV)
Pfizer

Completed

A Study To Investigate The Clearance Of PF-04776548 From The Body Following A Very Low (Micro) Dose Of The Compound Using A Low Level Of Radiotracer To Help Quantify Expected Low Concentrations Of PF-04776548 In The Body

Human Immunodeficiency Virus (HIV)

United Kingdom
Lederle Laboratories

Completed

An Open-Label, Crossover Study to Assess the Effect of Food on the Oral Bioavailability and Pharmacokinetic Profile of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects

HIV Infections

United States
ViiV Healthcare
GlaxoSmithKline

Completed

Study Of An Investigational Regimen Including FDA Approved HIV Drugs In HIV-Infected Pediatric Subjects

HIV Infections | Infection, Human Immunodeficiency Virus

United States, Portugal, Russian Federation, Mexico, Argentina, South Africa, Puerto Rico
Janssen-Cilag S.p.A.

Completed

An Italian Observation of Antiretroviral Treatment in Participants Taking Darunavir/ Cobicistat Plus Emtricitabine and Tenofovir Alafenamide Fumarate (DIAMANTE)

Human Immunodeficiency Virus (HIV)

Italy
Johns Hopkins University
amfAR, The Foundation for AIDS Research

Completed

Effect of Seminal Fluid on the Colon Wall; Implications for HIV Transmission

Human Immunodeficiency Virus (HIV)

United States
Karolinska Institutet
Hanoi Medical University

Unknown

Antiretroviral Treatment Strategies in Relation to Adherence, Resistance and Virological Treatment Failure (DotArv)

Human Immunodeficiency Virus (HIV)

Vietnam
Lederle Laboratories

Completed

An Ascending, Single Oral Dose Pharmacokinetic Study of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects

HIV Infections

United States
Rockefeller University
Aarhus University Hospital; University Hospital of Cologne

Completed

Romidepsin Plus 3BNC117 Phase 2a Study (ROADMAP)

Human Immunodeficiency Virus (HIV)

Germany, Denmark, United States
CytoDyn, Inc.

Active, not recruiting

An Extension Protocol for Subjects Who Successfully Completed PRO140_CD02 Study

Hiv | Human Immunodeficiency Virus
CytoDyn, Inc.

Active, not recruiting

An Extension of Protocol PRO 140_CD01 TS Study

HIV | Human Immunodeficiency Virus

United States
Sangamo Therapeutics

Completed

Repeat Doses of SB-728mR-T After Cyclophosphamide Conditioning in HIV-Infected Subjects on HAART

Human Immunodeficiency Virus (HIV)

United States
University of Pennsylvania
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

A Phase I Study of T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728mR in HIV-Infected Patients

Human Immunodeficiency Virus (HIV)

United States
Medical College of Wisconsin
National Institute of Mental Health (NIMH)

Completed

Regular HIV Testing Among At-Risk Latino Men

Human Immunodeficiency Virus (HIV)
PATH
National Institute of Allergy and Infectious Diseases (NIAID); National Institutes... and other collaborators

Completed

Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278LA, for Pre-Exposure Prophylaxis (TMC278LA)

Human Immunodeficiency Virus (HIV)

United States, South Africa, Zimbabwe
Rockefeller University
University Hospital of Cologne

Completed

3BNC117 and 10-1074 in HIV-infected Individuals

Human Immunodeficiency Virus (HIV)

United States, Germany
Drexel University
National Institute of Allergy and Infectious Diseases (NIAID)

Withdrawn

PRO 140 for Human Immunodeficiency Virus Infection

HIV

United States
University of Colorado, Denver

No longer available

Compassionate Use of Ibalizumab for the Treatment of HIV Infection

Human Immunodeficiency Virus (HIV)

United States
St. Jude Children's Research Hospital

Completed

Body Image in Youth With HIV

HIV | Human Immunodeficiency Virus

United States
Starpharma Pty Ltd
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

SPL7013 Gel - Male Tolerance Study

Human Immunodeficiency Virus (HIV)

Australia
Glaxo Wellcome

Completed

A Phase I Study to Evaluate the Pharmacokinetics, Safety and Antiviral Effects of Concurrent Administration of Zidovudine (AZT) and 2'3'-Dideoxyinosine (ddI) in Patients With Human Immunodeficiency Virus (HIV)

HIV Infections

United States
University of California, San Francisco
National Institute on Minority Health and Health Disparities (NIMHD); Florida...

Completed

The OPENS Trial: Offering Women PrEP (Aim 1)

Sexually Transmitted Diseases | Human Immunodeficiency Virus Transmission

United States
ViiV Healthcare
GlaxoSmithKline

Completed

An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir (DTG) Plus Lamivudine (3TC) With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Participants (Gemini 2)

HIV Infections | Infection, Human Immunodeficiency Virus

United States, Argentina, Spain, Germany, Belgium, Australia, Canada, United Kingdom, Italy, Romania, Taiwan, Russian Federation, Mexico, France, Switzerland, Peru, Poland, Portugal
Guangxi Medical University
Guilin Medical College; Second Affiliated Hospital of Guangzhou Medical University and other collaborators

Unknown

Comparative Study of Human Immunodeficiency Virus Negative Host Talaromyces Between Voriconazole and Amphotericin Sequential Itraconazole Therapy (CSHHTVASIT)

Talaromyces in Human Immunodeficiency Virus Negative | To Compare Voriconazole and Amphotericin Sequential Itraconazole Therapy | To Dynamically Monitor the Anti-Interferon-γ Autoantibodies

China
University of North Carolina, Chapel Hill
National Institute on Drug Abuse (NIDA); Johns Hopkins University; Thai Nguyen...

Completed

Reducing Hazardous Alcohol Use & Human Immunodeficiency Virus (HIV) Viral Load (REDART)

Alcohol Drinking | HIV

Vietnam
ViiV Healthcare
GlaxoSmithKline

Completed

HIV Treatment and CVD Events

HIV Infection | Cardiovascular Disease | Acute Myocardial Infarction | Infection, Human Immunodeficiency Virus
University of Guadalajara

Completed

Effect of Aerobic Training and Ginkgo Biloba on Lipids Levels in HIV-positive Patients Undergoing Antiretroviral Treatment

Human Immunodeficiency Virus

Mexico
Instituto Nacional de Salud Publica, Mexico
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran; Instituto...

Unknown

Diagnosis and Treatment of Co-infection With Human Immunodeficiency Virus /Latent Tuberculosis Infection (HIV/TBL) (HIV/TB)

Human Immunodeficiency Virus (HIV) | Tuberculosis (TB) | Latent Tuberculosis Infection (LTI)

Mexico
University of Michigan
Beira Operational Research Center

Completed

Interventions to Improve HIV Antiretroviral Therapy Adherence

Human Immunodeficiency Virus (HIV) Infection

Mozambique

Clinical Trials on Human Immunodeficiency Virus (HIV)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guatemala

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations